Disparities Exist in Wait-Listing for Pediatric Kidney Transplants
By Lori Solomon HealthDay Reporter
THURSDAY, Aug. 1, 2024 -- Disparities in timely wait-listing among pediatric kidney transplant candidates expose some patients to greater harms from dialysis, according to a study published online Aug. 1 in Pediatrics.
Lindsey M. Maclay, from the Columbia University Vagelos College of Physicians and Surgeons in New York City, and colleagues assessed disparities in timely access to transplant wait-listing among 4,506 children (ages 3 to 17 years) added to the U.S. kidney transplant wait list in 2015 to 2019.
The researchers found that female sex, Hispanic ethnicity, Black race, and public insurance were associated with a lower adjusted relative risk for preemptive wait-listing (that is, wait-list addition before receiving dialysis), which was not associated with time from wait-list activation to transplantation (adjusted hazard ratio 0.94; 95 percent confidence interval, 0.87 to 1.02). Nearly two-thirds of transplant recipients wait-listed preemptively had no pretransplant dialysis (68 percent), whereas recipients listed nonpreemptively had a median 1.6 years of dialysis at transplant. For 415 candidates initiating dialysis as children but wait-listed as adults, the transplant rate was lower compared with nonpreemptive pediatric candidates after wait-list activation (adjusted hazard ratio, 0.54; 95 percent confidence interval, 0.44 to 0.66).
"Disparities in timely wait-listing are associated with differences in pretransplant dialysis exposure despite no difference in time to transplant after wait-list activation," the authors write. "Young adults who experience delays may miss pediatric prioritization, highlighting an area for policy intervention."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Rebound Weight Gain Common After Discontinuing Antiobesity Medications
FRIDAY, July 25, 2025 -- Antiobesity medications (AOMs) yield weight loss during use, followed by weight regain after discontinuation of treatment, according to a review published...
Patients Face High Out-of-Pocket Costs After Incident Cancer Diagnosis
FRIDAY, July 25, 2025 -- Patients face high out-of-pocket costs (OOPCs) after an incident diagnosis of cancer, with costs increasing with stage of diagnosis, according to a study...
Exposure to PFAS Mixtures Linked to Increased Odds of Type 2 Diabetes
FRIDAY, July 25, 2025 -- In multiethnic populations, exposure to per- and polyfluoroalkyl substance (PFAS) mixtures may be associated with increased odds of type 2 diabetes (T2D)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.